Physical interaction with Ephrin B1 promotes CXCR4 intracellular localization and oncogenic potential

Read full text
Authors: Alessandro Rabbito, Omolade Otun, Amos Fumagalli, Ana Alonso Bartolomé, Sonya Galant, Martial Sevéno, Manuel Counson, Thierry Durroux, Chérine Bechara, Martine J. Smit, Sébastien Granier, Martyna Szpakowska
+3 more Andy Chevigné, Séverine Chaumont‐Dubel, Philippe Marin
Cited by: 0
References: 32

Abstract

Abstract Chemokine receptor 4 (CXCR4) is a member of the chemokine receptor exclusively activated by the chemokine CXCL12. While CXCR4 regulates numerous physiological processes associated with cell migration and embryogenesis, its overexpression has been involved in various cancer types. Studies suggest that intracellular CXCR4 expression rather than CXCR4-operated signaling underlies its pro-tumorigenic functions. Given the role of GPCR interacting proteins in their trafficking and subcellular localization, we characterized the CXCR4 interactome using an affinity purification coupled to mass spectrometry (AP-MS) strategy. The most abundant protein identified in the CXCR4 interactome is Ephrin B1, a member of the Ephrin protein family that shares several functions with CXCR4, such as the regulation of cell migration and proliferation. Further studies showed that interaction between CXCR4 and Ephrin B1 is direct and enhanced by treating cell with CXCL12. They also indicated that Ephrin B1 prevents CXCR4 N-glycosylation, decreases CXCR4 cell surface expression and consistently inhibits CXCL12-induced CXCR4 coupling to G αi1-3 and the recruitment of β-arrestins 1 and 2. Conversely, Ephrin B1 signals to Erk1,2 through CXCR4 activation and mediates the decrease in Death Receptor 5 expression elicited by intracellular CXCR4. Collectively, these findings identify Ephrin B1 as a key mediator of CXCR4 tumorigenic signaling.

Fields of Study & Subjects

Axon Guidance and Neuronal Signaling Phagocytosis and Immune Regulation Glycosylation and Glycoproteins Research

Publication details

Journal / source
Cellular and Molecular Life Sciences
Publisher
Springer Science and Business Media LLC
Volume
83
Issue
1
Publication date
24 June 2026
Language
EN